Get the Stockscreener App
2.13
5.33%
-0.12
Onkure Therapeutics Inc Stock (OKUR) Forecast
The Onkure Therapeutics Inc (OKUR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.776, representing a -16.62% decrease from the current price of $2.13. The highest analyst price target is $3.4686, and the lowest is $0.0835.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OKUR Price Target
Average 4.9275
(+131.34% Upside)
Is Onkure Therapeutics Inc (OKUR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.61 | Buy |
| STOCH(9,6) | 27.46 | Neutral |
| STOCHRSI(14) | 30.95 | Neutral |
| MACD(12,26) | -0.2884 | Sell |
| ADX(14) | 27.84 | Sell |
| William %R | -94.93 | Buy |
| CCI(14) | -69.33 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.3855
Sell
|
2.3869
Sell
|
| MA20 |
2.618
Sell
|
2.5995
Sell
|
| MA50 |
3.2568
Sell
|
3.0865
Sell
|
| MA100 |
3.7484
Sell
|
3.4289
Sell
|
| MA200 |
3.6401
Sell
|
3.4731
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, OKUR could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on OKUR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.61 indicates that OKUR is oversold. This indicates that OKUR price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 27.46 indicates that OKUR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.95 indicates that OKUR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.84 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -69.33 indicates that OKUR is still oversold but not to an extreme extent.
Long-term OKUR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Onkure Therapeutics Inc financial reports and earnings history, Onkure Therapeutics Inc (OKUR) stock could reach $18.41 by 2030, $25.42 by 2040 and $144.15 by 2050. See the projected annual prices until 2050 of the Onkure Therapeutics Inc stock below:
- Onkure Therapeutics Inc (OKUR) is expected to reach an average price of $25.96 in 2035, with a high prediction of $27.70 and a low estimate of $26.03. This indicates an $1,119% rise from the last recorded price of $2.13.
- Onkure Therapeutics Inc (OKUR) stock is projected to chart a bullish course in 2040, with an average price target of $22.40, representing an $951.68% surge from its current level. The forecast ranges from a conservative $22.87 to a sky-high $25.42.
- Our analysts predict Onkure Therapeutics Inc (OKUR) to jump 5,832% by 2045, soaring from $14.55 to an average price of $126.35, potentially reaching $126.27. While $14.55 is the low estimate, the potential upside is significant.
- Onkure Therapeutics Inc (OKUR) stock is expected to climb by 2050, reaching an average of $140.02, a $6,474% jump from its current level. However, a wide range of estimates exists, with high and low targets of $144.15 and $140.47, respectively, highlighting the market's uncertainty.
Onkure Therapeutics Inc Stock (OKUR) Year by Year Forecast
Onkure Therapeutics Inc Stock (OKUR) Price Forecast for 2026
The predicted value for Onkure Therapeutics Inc (OKUR) in 2026 is set at an average of $2.7318. Estimates vary from a peak of $5.38 to a trough of $0.0835, indicating an +28.25% surge from the present price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.1457 | $0.0835 | $3.4686 | -46.21% |
| December, 2026 | $5.1172 | $0.63 | $1.055 | +140.24% |
Onkure Therapeutics Inc Stock (OKUR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Onkure Therapeutics Inc (OKUR) is $7.6929, with a high forecast of $9.7714 and a low forecast of $5.6144. This indicates an +261.17% increase from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.53 | $6.17 | $6.0486 | +159.63% |
| February, 2027 | $7.8729 | $7.3557 | $7.9622 | +269.62% |
| March, 2027 | $8.4065 | $8.3236 | $8.0465 | +294.67% |
| April, 2027 | $8.6493 | $8.5879 | $8.283 | +306.07% |
| May, 2027 | $9.8629 | $9.78 | $9.7029 | +363.05% |
| June, 2027 | $9.7258 | $9.8136 | $9.7714 | +356.61% |
| July, 2027 | $9.0286 | $8.9979 | $9.0565 | +323.88% |
| August, 2027 | $8.4722 | $8.5322 | $8.7201 | +297.76% |
| September, 2027 | $8.2851 | $8.3294 | $8.2344 | +288.97% |
| October, 2027 | $7.0979 | $7.2979 | $7.3658 | +233.24% |
| November, 2027 | $6.5415 | $6.6395 | $6.9894 | +207.11% |
| December, 2027 | $5.3844 | $5.6144 | $5.9322 | +152.79% |
Onkure Therapeutics Inc Stock (OKUR) Price Forecast for 2028
In 2028, Onkure Therapeutics Inc (OKUR) is projected to reach an average price of $2.6507, with a high projection of $5.2798 and a low estimate of $0.0216. This indicates an +24.45% rise from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1179 | $5.6079 | $5.2798 | +140.28% |
| February, 2028 | $4.8008 | $5.0507 | $4.7501 | +125.39% |
| March, 2028 | $4.2937 | $4.3637 | $4.5216 | +101.58% |
| April, 2028 | $4.1465 | $4.3564 | $4.2758 | +94.67% |
| May, 2028 | $2.1601 | $2.5394 | $3.7273 | +1.41% |
| June, 2028 | $0.673 | $1.473 | $1.7708 | -68.40% |
| July, 2028 | $1.9166 | $0.6344 | $1.0616 | -10.02% |
| August, 2028 | $0.3994 | $0.5394 | $0.6373 | -81.25% |
| September, 2028 | $0.4577 | $0.0216 | $0.6677 | -78.51% |
| October, 2028 | $0.6141 | $0.0749 | $0.9641 | -71.17% |
| November, 2028 | $0.5813 | $0.4234 | $1.222 | -72.71% |
| December, 2028 | $0.3284 | $0.1241 | $1.0898 | -84.58% |
Onkure Therapeutics Inc Stock (OKUR) Price Forecast for 2029
The 2029 price forecast for Onkure Therapeutics Inc Stock (OKUR) is $11.07 on average, with a high prediction of $22.13 and a low estimate of $0.0177. This represents an +419.93% increase from the previous price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.92 | $0.0177 | $13.08 | +553.52% |
| February, 2029 | $15.10 | $15.11 | $14.18 | +608.72% |
| March, 2029 | $15.01 | $15.31 | $14.29 | +604.76% |
| April, 2029 | $20.64 | $16.36 | $20.79 | +868.95% |
| May, 2029 | $22.62 | $20.67 | $22.10 | +962.18% |
| June, 2029 | $21.87 | $22.23 | $21.57 | +926.76% |
| July, 2029 | $21.68 | $21.71 | $21.49 | +917.71% |
| August, 2029 | $22.29 | $21.64 | $22.13 | +946.62% |
| September, 2029 | $22.31 | $22.05 | $22.06 | +947.36% |
| October, 2029 | $20.39 | $20.52 | $21.77 | +857.08% |
| November, 2029 | $19.70 | $19.76 | $20.02 | +824.96% |
| December, 2029 | $18.69 | $18.77 | $19.14 | +777.40% |
Onkure Therapeutics Inc Stock (OKUR) Price Forecast for 2030
Onkure Therapeutics Inc Stock (OKUR) is expected to reach an average price of $11.34 in 2030, with a high forecast of $18.41 and a low forecast of $4.2631. This signifies an +432.24% surge from the last price of $2.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.18 | $17.27 | $18.41 | +706.78% |
| February, 2030 | $16.47 | $16.54 | $16.72 | +673.25% |
| March, 2030 | $15.25 | $15.33 | $15.89 | +615.77% |
| April, 2030 | $14.25 | $14.17 | $14.35 | +569.16% |
| May, 2030 | $12.87 | $13.07 | $13.50 | +504.17% |
| June, 2030 | $11.78 | $12.22 | $12.57 | +453.26% |
| July, 2030 | $11.31 | $11.38 | $11.38 | +431.06% |
| August, 2030 | $8.9974 | $9.6974 | $10.73 | +322.41% |
| September, 2030 | $7.2845 | $7.6145 | $7.8017 | +242.00% |
| October, 2030 | $5.9002 | $5.9702 | $6.286 | +177.01% |
| November, 2030 | $5.476 | $5.7056 | $6.1381 | +157.09% |
| December, 2030 | $3.9231 | $4.2631 | $4.8874 | +84.18% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):